All sponsors

Neurocrine Biosciences $NBIX

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS17
PHASE 3 / 2-312
RECRUITING12
READOUTS ≤12 MONTHS7
READOUT SLIPPED >6 MO17%

Delay Index: of 12 active trials registered more than a year ago, 2 have moved their primary completion (readout) date by more than 6 months since first registration (median +0.0 months). See all sponsors →

Open Neurocrine Biosciences on the live radar map → 📅 $NBIX readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Crinecerfont
NCT04806451
P3Active, not recruitingCongenital Adrenal Hyperplasia1032023-03-10
CAHtalyst
NCT04490915
P3Active, not recruitingCongenital Adrenal Hyperplasia1822023-07-19 (+6 mo)
NBI-1065890
NCT07365462
P2RecruitingTardive Dyskinesia1002027-02
NBI-1065845
NCT06911112
P3RecruitingMajor Depressive Disorder2002027-07
NBI-1065845
NCT06786624
P3RecruitingMajor Depressive Disorder2002027-07 (+8 mo)
NBI-1065845
NCT06963021
P3RecruitingMajor Depressive Disorder2002027-07
NBI-1117570
NCT07288333
P2RecruitingSchizophrenia1202027-08
NBI-1117568
NCT06963034
P3RecruitingSchizophrenia2842027-10
NBI-1117568
NCT07105098
P3RecruitingSchizophrenia2842027-11
NBI-1117568
NCT07288320
P2RecruitingBipolar I Disorder; Mania1502028-02
NBIP-01435
NCT07850739
P2Not yet recruitingCongenital Adrenal Hyperplasia362028-03-16
Valbenazine
NCT06312189
P3Enrolling by invitationChorea, Huntington72028-04 (+25 mo)
NBI-1117567
NCT07832383
P2Not yet recruitingAlzheimer's Disease1352028-05
Osavampator
NCT07196501
P3RecruitingMajor Depressive Disorder5502028-07
NBI-1065845
NCT06966401
P3RecruitingMajor Depressive Disorder8502029-05
NBI-1117568
NCT07227818
P3RecruitingSchizophrenia5602029-07
NBI-1117568
NCT07114874
P3RecruitingSchizophrenia6002031-12